Výběr Všechno Hledat Přihlásit se

Hledat

#HealthcareInnovation
S
Austin American-Statesman @statesman.com · 1 min

#Telemedicine #HealthcareInnovation #Startups

Link Preview
www.statesman.com
A tale of two San Antonio health tech startups that team up on telehealth
Tú TeleDoc was founded in early 2025 to break into the market for telemedicine. It's not the founders' first rodeo. A group of San Antonio tech veterans wants to use telemedicine to increase access to healthcare in Mexico and South America.
Avatar
Social News XYZ @socialnews.xyz · 4 min

#ArtificialIntelligence #HealthcareInnovation #PublicHealth

Link Preview
www.socialnews.xyz
India's first government AI clinic to boost public health system
Dubai/New Delhi, Jan 5 (SocialNews. XYZ) India's first government-run artificial intelligence (AI) clinic, launched recently at the Government Institute of Medical Sciences (GIMS) in Greater Noida, marks a major step in integrating advanced technology in the public health system of the country, according to a media report.
Avatar
Post and Courier @postandcourier.com · 1 h

#ArtificialIntelligence #HealthcareInnovation #CancerPrevention

Link Preview
www.postandcourier.com
AI speeds up processing of cancer prevention tests at MUSC but humans still needed
Patricia Houser, cytopathology lab manager, sifts through Pap smear samples looking for potentially cancerous cells, Wednesday, December 3, 2025, in Charleston.
Avatar
Medscape @medscape.com · 2 d

#GeneEditing #BetaThalassemia #HealthcareInnovation

Link Preview
www.medscape.com
Gene-Editing Breakthrough Ends Transfusions for UK Patient
The first successful gene-editing treatment for beta thalassaemia has been delivered at University College London Hospital (UCLH), marking a milestone for patients with the inherited blood disorder.
S
StreetInsider.com @streetinsider.com · 3 d

#HealthcareInnovation #TemperatureControl #PatientSafety

Link Preview
www.streetinsider.com
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026
Vancouver, British Columbia--(Newsfile Corp. - January 2, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to provide a positive recap on the year as well as a strategic outlook for the year ahead in 2026.

Trendy pro vás

Koho sledovat

Avatar
Dárek pro Putina
@DarPutinovi
Avatar
The Dallas Morning News
@dallasnews.com
Avatar
Scientific American
@scientificamerican.com